← 產業報告目錄
AI-Powered Drug Discovery in Dermatology Market Size, Share & Trends Analysis Report By AI Model (Machine Learning (ML) (Supervised Learning, Reinforcement Learning, Unsupervised Learning, Others), Deep Learning (Convolutional Neural Networks (CNNs), Neural Networks, Others), Natural Language Processing (NLP), Generative Models (Transformer Models, GANs (Generative Adversarial Networks), Others), Others), By Drug Type, By Indication, By End-User, by Region, And by Segment Forecasts, 2025-2034.
出版商 InsightAce Analytic產業別 ICT & Media出版日期 2026-02-20頁數 180報告編號 INSIGHTACE-93f9d4cc99
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The AI-Powered Drug Discovery in Dermatology Market on a global scale was estimated at USD 234.7 Mn in 2024 and is expected to attain USD 1,924.6 Bn by 2034, with a projected CAGR of 24.2% between 2025 and 2034.
At its core, AI-Powered Drug Discovery in Dermatology pertains to surgingly turning to these solutions to meet contemporary demands.
The market's upward path is propelled by surging healthcare spending, technological evolution, and the surging focus on personalized and precision-based approaches in technology and communications.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, propelled by rapid industrialization and expanding end-user bases.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global AI-Powered Drug Discovery in Dermatology Market Snapshot
Chapter 4. Global AI-Powered Drug Discovery in Dermatology Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2034
4.8. Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.9. Use/impact of AI on AI-Powered Drug Discovery in Dermatology Market Industry Trends
4.10. Global AI-Powered Drug Discovery in Dermatology Market Penetration & Growth Prospect Mapping (US$ Mn), 2021-2034
Chapter 5. AI-Powered Drug Discovery in Dermatology Market Segmentation 1: By Drug Type, Estimates & Trend Analysis
5.1. Market Share by Drug Type, 2024 & 2034
5.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Drug Type:
5.2.1. Small Molecules
5.2.2. Biologics
5.2.3. Biosimilars
5.2.4. Natural Compounds
5.2.5. RNA-Based Therapeutics
5.2.6. Others
Chapter 6. AI-Powered Drug Discovery in Dermatology Market Segmentation 2: By AI Model, Estimates & Trend Analysis
6.1. Market Share by AI Model, 2024 & 2034
6.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following AI Model:
6.2.1. Machine Learning (ML)
6.2.1.1. Supervised Learning
6.2.1.2. Unsupervised Learning
6.2.1.3. Reinforcement Learning
6.2.1.4. Others
6.2.2. Deep Learning
6.2.2.1. Neural Networks
6.2.2.2. Convolutional Neural Networks (CNNs)
6.2.2.3. Others
6.2.3. Natural Language Processing (NLP)
6.2.4. Generative Models
6.2.4.1. GANs (Generative Adversarial Networks)
6.2.4.2. Transformer Models
6.2.4.3. Others
Chapter 7. AI-Powered Drug Discovery in Dermatology Market Segmentation 3: By Indication, Estimates & Trend Analysis
7.1. Market Share by Indication, 2024 & 2034
7.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Indication:
7.2.1. Psoriasis
7.2.2. Atopic Dermatitis (Eczema)
7.2.3. Acne
7.2.4. Skin Cancer (e.g., Melanoma, Basal Cell Carcinoma)
7.2.5. Vitiligo
7.2.6. Wound Healing
7.2.7. Rare Dermatological Disorders
7.2.8. Others
Chapter 8. AI-Powered Drug Discovery in Dermatology Market Segmentation 3: By End User, Estimates & Trend Analysis
8.1. Market Share by End User, 2024 & 2034
8.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following End User:
8.2.1. Pharmaceutical Companies
8.2.2. Biotechnology Firms
8.2.3. Academic and Research Institutes
8.2.4. Contract Research Organizations (CROs)
8.2.5. Healthcare Providers
Chapter 9. AI-Powered Drug Discovery in Dermatology Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. Global AI-Powered Drug Discovery in Dermatology Market, Regional Snapshot 2024 & 2034
9.2. North America
9.2.1. North America AI-Powered Drug Discovery in Dermatology Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.2.1.1. US
9.2.1.2. Canada
9.2.2. North America AI-Powered Drug Discovery in Dermatology Market Revenue (US$ Million) Estimates and Forecasts by Drug Type, 2021-2034
9.2.3. North America AI-Powered Drug Discovery in Dermatology Market Revenue (US$ Million) Estimates and Forecasts by AI Model, 2021-2034
9.2.4. North America AI-Powered Drug Discovery in Dermatology Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2021-2034
9.2.5. North America AI-Powered Drug Discovery in Dermatology Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
9.3. Europe
9.3.1. Europe AI-Powered Drug Discovery in Dermatology Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.3.1.1. Germany
9.3.1.2. U.K.
9.3.1.3. France
9.3.1.4. Italy
9.3.1.5. Spain
9.3.1.6. Rest of Europe
9.3.2. Europe AI-Powered Drug Discovery in Dermatology Market Revenue (US$ Million) Estimates and Forecasts by Drug Type, 2021-2034
9.3.3. Europe AI-Powered Drug Discovery in Dermatology Market Revenue (US$ Million) Estimates and Forecasts by AI Model, 2021-2034
9.3.4. Europe AI-Powered Drug Discovery in Dermatology Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2021-2034
9.3.5. Europe AI-Powered Drug Discovery in Dermatology Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
9.4. Asia Pacific
9.4.1. Asia Pacific AI-Powered Drug Discovery in Dermatology Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.4.1.1. India
9.4.1.2. China
9.4.1.3. Japan
9.4.1.4. Australia
9.4.1.5. South Korea
9.4.1.6. Hong Kong
9.4.1.7. Southeast Asia
9.4.1.8. Rest of Asia Pacific
9.4.2. Asia Pacific AI-Powered Drug Discovery in Dermatology Market Revenue (US$ Million) Estimates and Forecasts by Drug Type, 2021-2034
9.4.3. Asia Pacific AI-Powered Drug Discovery in Dermatology Market Revenue (US$ Million) Estimates and Forecasts by AI Model, 2021-2034
9.4.4. Asia Pacific AI-Powered Drug Discovery in Dermatology Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2021-2034
9.4.5. Asia Pacific AI-Powered Drug Discovery in Dermatology Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
9.5. Latin America
9.5.1. Latin America AI-Powered Drug Discovery in Dermatology Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.5.1.1. Brazil
9.5.1.2. Mexico
9.5.1.3. Rest of Latin America
9.5.2. Latin America AI-Powered Drug Discovery in Dermatology Market Revenue (US$ Million) Estimates and Forecasts by Drug Type, 2021-2034
9.5.3. Latin America AI-Powered Drug Discovery in Dermatology Market Revenue (US$ Million) Estimates and Forecasts by AI Model, 2021-2034
9.5.4. Latin America AI-Powered Drug Discovery in Dermatology Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2021-2034
9.5.5. Latin America AI-Powered Drug Discovery in Dermatology Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
9.6. Middle East & Africa
9.6.1. Middle East & Africa Wind Turbine Rotor Blade Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.6.1.1. GCC Countries
9.6.1.2. Israel
9.6.1.3. South Africa
9.6.1.4. Rest of Middle East and Africa
9.6.2. Middle East & Africa AI-Powered Drug Discovery in Dermatology Market Revenue (US$ Million) Estimates and Forecasts by Drug Type, 2021-2034
9.6.3. Middle East & Africa AI-Powered Drug Discovery in Dermatology Market Revenue (US$ Million) Estimates and Forecasts by AI Model, 2021-2034
9.6.4. Middle East & Africa AI-Powered Drug Discovery in Dermatology Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2021-2034
9.6.5. Middle East & Africa AI-Powered Drug Discovery in Dermatology Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Almirall
10.2.1.1. Business Overview
10.2.1.2. Key Drug Type/Service Overview
10.2.1.3. Financial Performance
10.2.1.4. Geographical Presence
10.2.1.5. Recent Developments with Business Strategy
10.2.2. SCARLETRED
10.2.3. QIMA Monasterium
10.2.4. Quantificare
10.2.5. Google
10.2.6. Microsoft
10.2.7. CytoReason LTD
10.2.8. Atomwise Inc.
10.2.9. Among Others
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們